Cigna Group (NYSE:CI) Price Target Raised to $320.00

Cigna Group (NYSE:CI) had its price target increased by Barclays from $310.00 to $320.00 in a research report report published on Monday morning,Benzinga reports. Barclays currently has an equal weight rating on the health services provider’s stock.

CI has been the subject of several other reports. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a report on Friday, July 31st. Guggenheim cut their target price on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Sunday. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 price target on shares of Cigna Group in a research note on Thursday, October 1st. Finally, Evercore initiated coverage on Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target for the company. Fourteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $340.80.

Cigna Group Trading Down 0.6%

Shares of CI opened at $301.25 on Monday. The company has a market capitalization of $79.38 billion, a P/E ratio of 9.58, a P/E/G ratio of 1.13 and a beta of 0.25. Cigna Group has a one year low of $257.85 and a one year high of $318.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The stock has a 50-day moving average price of $287.03 and a 200 day moving average price of $282.49.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. The company had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. Cigna Group’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business earned $7.83 EPS. Sell-side analysts forecast that Cigna Group will post 30.72 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group’s dividend payout ratio is 27.54%.

Insiders Place Their Bets

In other news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cigna Group

A number of large investors have recently bought and sold shares of CI. BlackRock Inc. raised its position in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after purchasing an additional 840,098 shares during the period. GQG Partners LLC acquired a new position in Cigna Group during the 2nd quarter valued at approximately $1,628,918,000. Bank of America Corp DE grew its stake in Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after buying an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after buying an additional 236,340 shares during the last quarter. Finally, Boston Partners grew its stake in Cigna Group by 17.9% during the 3rd quarter. Boston Partners now owns 2,374,437 shares of the health services provider’s stock worth $645,467,000 after buying an additional 359,777 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Key Headlines Impacting Cigna Group

These are some of the CI headlines that stood out recently:

• Positive Sentiment: Barclays raised its price target for CI, indicating a more favorable analyst view; the report provided here does not specify the new target or rationale. Article: Cigna Group Stock Price Target Raised at Barclays
• Positive Sentiment: A technical analysis noted that shares moved above the 20-day moving average, which the report interprets as a short-term bullish signal. This is a trading indicator rather than a change in business fundamentals. Article: Cigna Recently Broke Out Above the 20-Day Moving Average
• Negative Sentiment: The latest outlook coverage says risks persist, tempering the benefit of the higher 2026 outlook. The available article details do not specify which risks are involved. Article: The Cigna Group stock gains as 2026 outlook rises, risks persist

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.